ETFs Dechra Pharmaceuticals

DPH

GB0009633180

Market Closed - London S.E. 02:30:00 2024-01-16 EST			5-day change	1st Jan Change
3,866.00 ^GBX	-.--%		-.--%	-

08-16	Dechra Pharmaceuticals PLC Announces Appointment of Justine Conway as Chief Corporate Strategy and Business Development Officer	CI
06-25	Dechra Opens New Global Headquarters in Boston and Invests $60,000 in Local Community Partnerships	CI

ETFs positioned on Dechra Pharmaceuticals

Name	YTD change	Weight	AuM
CI INTERNATIONAL QUALITY DIVIDEND GROWTH INDEX ETF (UNHEDGED) - CAD	+3.57%	0.05%	137 M€
STATE STREET SPDR PORTFOLIO EUROPE ETF - USD	+3.55%	0.05%	742 M€
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	+4.47%	0.02%	33,076 M€
VANGUARD ETHICALLY CONSCIOUS INTERNATIONAL SHARES INDEX ETF - AUD	+4.57%	0.01%	1,091 M€
CI EQUITY ASSET ALLOCATION ETF - CAD	+13.95%	0.01%	39 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+13.13%	0.01%	12,086 M€
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR	+3.64%	0%	52 M€
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF - DISTRIBUTING - EUR	-0.47%	0%	18 M€
CI MARRET ALTERNATIVE ABSOLUTE RETURN BOND ETF - CAD	0.00%	-0%	12 M€

Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).

Employees

Sector

More about the company

ETFs Dechra Pharmaceuticals

Stocks

DPH

GB0009633180

ETFs positioned on Dechra Pharmaceuticals

Company Profile